190 related articles for article (PubMed ID: 33768405)
1. Evaluation of Ac-Lys
Dijkstra BM; de Jong M; Stroet MCM; Andreae F; Dulfer SE; Everts M; Kruijff S; Nonnekens J; den Dunnen WFA; Kruyt FAE; Groen RJM
J Neurooncol; 2021 Jun; 153(2):211-222. PubMed ID: 33768405
[TBL] [Abstract][Full Text] [Related]
2. Necrosis binding of Ac-Lys
Stroet MCM; Dijkstra BM; Dulfer SE; Kruijff S; den Dunnen WFA; Kruyt FAE; Groen RJM; Seimbille Y; Panth KM; Mezzanotte L; Lowik CWGM; de Jong M
EJNMMI Res; 2021 May; 11(1):47. PubMed ID: 33970376
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of bevacizumab-IRDye800CW as a tracer for fluorescence-guided meningioma surgery.
Dijkstra BM; Nonnekens J; Nagengast W; Kruijff S; Meersma GJ; den Dunnen WFA; Kruyt FAE; Groen RJM
J Neurosurg; 2023 May; 138(5):1263-1272. PubMed ID: 36308486
[TBL] [Abstract][Full Text] [Related]
4. Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice.
Klomp MJ; van den Brink L; van Koetsveld PM; de Ridder CMA; Stuurman DC; Löwik CWGM; Hofland LJ; Dalm SU
Life Sci; 2023 Dec; 334():122173. PubMed ID: 37907154
[TBL] [Abstract][Full Text] [Related]
5. Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate.
Ma MT; Cullinane C; Waldeck K; Roselt P; Hicks RJ; Blower PJ
EJNMMI Res; 2015 Dec; 5(1):52. PubMed ID: 26452495
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of [
Njotu FN; Ketchemen JP; Tikum AF; Babeker H; Gray BD; Pak KY; Uppalapati M; Fonge H
J Nucl Med; 2024 Apr; 65(4):533-539. PubMed ID: 38485273
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts.
Santini C; Kuil J; Bunschoten A; Pool S; de Blois E; Ridwan Y; Essers J; Bernsen MR; van Leeuwen FW; de Jong M
J Nucl Med; 2016 Aug; 57(8):1289-95. PubMed ID: 27127222
[TBL] [Abstract][Full Text] [Related]
8. [
Cappuzzo J; Popoola D; Prasad D; Lipinski L
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35487628
[TBL] [Abstract][Full Text] [Related]
9.
Thakur S; Daley B; Millo C; Cochran C; Jacobson O; Lu H; Wang Z; Kiesewetter D; Chen X; Vasko V; Klubo-Gwiezdzinska J
Clin Cancer Res; 2021 Mar; 27(5):1399-1409. PubMed ID: 33355247
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic analysis of [
Bashir A; Vestergaard MB; Binderup T; Broholm H; Marner L; Ziebell M; Fugleholm K; Mathiesen T; Kjær A; Law I
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2577-2588. PubMed ID: 32170347
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models.
Zhang L; Vines DC; Scollard DA; McKee T; Komal T; Ganguly M; Do T; Wu B; Alexander N; Vali R; Shammas A; Besanger T; Baruchel S
Contrast Media Mol Imaging; 2017; 2017():9481276. PubMed ID: 29097943
[TBL] [Abstract][Full Text] [Related]
12. SSTR-2 as a potential tumour-specific marker for fluorescence-guided meningioma surgery.
Dijkstra BM; Motekallemi A; den Dunnen WFA; Jeltema JR; van Dam GM; Kruyt FAE; Groen RJM
Acta Neurochir (Wien); 2018 Aug; 160(8):1539-1546. PubMed ID: 29858948
[TBL] [Abstract][Full Text] [Related]
13. eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumors.
Chapeau D; Beekman S; Handula M; Murce E; de Ridder C; Stuurman D; Seimbille Y
EJNMMI Radiopharm Chem; 2024 May; 9(1):44. PubMed ID: 38775990
[TBL] [Abstract][Full Text] [Related]
14. Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor.
Edwards WB; Xu B; Akers W; Cheney PP; Liang K; Rogers BE; Anderson CJ; Achilefu S
Bioconjug Chem; 2008 Jan; 19(1):192-200. PubMed ID: 18020401
[TBL] [Abstract][Full Text] [Related]
15. Correction to: Evaluation of Ac-Lys
Dijkstra BM; de Jong M; Stroet MCM; Andreae F; Dulfer SE; Everts M; Kruijff S; Nonnekens J; den Dunnen WFA; Kruyt FAE; Groen RJM
J Neurooncol; 2021 Jun; 153(2):223. PubMed ID: 34014425
[No Abstract] [Full Text] [Related]
16. Robust labeling and comparative preclinical characterization of DOTA-TOC and DOTA-TATE.
Velikyan I; Xu H; Nair M; Hall H
Nucl Med Biol; 2012 Jul; 39(5):628-39. PubMed ID: 22336375
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Biological Evaluation of
Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of a dual sstr2 and integrin α
Liu B; Zhang Z; Wang H; Yao S
Bioorg Med Chem; 2019 Nov; 27(21):115094. PubMed ID: 31540828
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of [
Tafreshi NK; Pandya DN; Tichacek CJ; Budzevich MM; Wang Z; Reff JN; Engelman RW; Boulware DC; Chiappori AA; Strosberg JR; Ji H; Wadas TJ; El-Haddad G; Morse DL
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3408-3421. PubMed ID: 33772332
[TBL] [Abstract][Full Text] [Related]
20. Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue.
Rachinger W; Stoecklein VM; Terpolilli NA; Haug AR; Ertl L; Pöschl J; Schüller U; Schichor C; Thon N; Tonn JC
J Nucl Med; 2015 Mar; 56(3):347-53. PubMed ID: 25635133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
